Help! Male Hormones Dampen CD4+ T-cell Help in Cancer
Sex differences in antitumor immunity contribute to disparities in cancer outcomes, yet the role of CD4+ T helper cells in this context remains poorly understood. In this issue, Hunt and colleagues show that sex hormones restrain CD4+ T-cell help in males, weakening antitumor immune responses and promoting tumor progression. This work identifies CD4+ T-cell help as a previously underappreciated driver of sex-biased cancer immunity, with potential implications for sex-informed immunotherapy strategies. See related article by Hunt et al., p. XX .
Authors
- Juyeun Lee (ORCID: https://orcid.org/0000-0001-8276-5020)
- Justin D. Lathia (ORCID: https://orcid.org/0000-0003-3168-7290)
Institutions
- University of Copenhagen (DK)
- Cleveland Clinic (US)
- Cleveland Clinic Lerner College of Medicine (US)
- Cleveland Clinic Florida (US)
- Vaccine & Gene Therapy Institute of Florida (US)
- Case Comprehensive Cancer Center
- Case Western Reserve University (US)
Publication Details
- Journal
- Cancer Immunology Research
- Published
- 2026-05-21
- DOI
- https://doi.org/10.1158/2326-6066.cir-26-0513
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00